Allogeneic expanded adipose-derived stem cells in the treatment of rectovaginal fistulas in Crohn's disease, by Nikolic et al
- PMID: 33501776
- DOI: 10.1111/codi.15508
Allogeneic expanded adipose-derived stem cells in the treatment of rectovaginal fistulas in Crohn's disease, by Nikolic et al
Comment on
-
Allogeneic expanded adipose-derived stem cells in the treatment of rectovaginal fistulas in Crohn's disease.Colorectal Dis. 2021 Jan;23(1):153-158. doi: 10.1111/codi.15324. Epub 2020 Sep 4. Colorectal Dis. 2021. PMID: 32810356 Free PMC article.
References
REFERENCES
-
- Nikolic M, Stift A, Reinisch W, Vogelsang H, Matic A, Muller C, et al. Allogeneic expanded adipose-derived stem cells in the treatment of rectovaginal fistulas in Crohn's disease. Colorectal Dis. 2020; doi: https://doi.org/10.1111/codi.15324.
-
- Garcia-Arranz M, Herreros MD, Gonzalez-Gomez C, de la Quintana P, Guadalajara H, Georgiev-Hristov T, et al. Treatment of Crohn's-related rectovaginal fistula with allogeneic expanded-adipose derived stem cells: a phase I-IIa clinical trial. Stem Cells Transl Med. 2016;5:1441-6.
-
- Panes J, Garcia-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, et al. Long-term efficacy and safety of stem cell therapy (Cx601) for complex perianal fistulas in patients with Crohn's Disease. Gastroenterology. 2018;154:1334-42.e4.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
